Giant Gene Discovered
In 2006, researchers in Finland discovered that a mutation in the AIP gene on chromosome 11 causes gigantism in some families. Afterward, Professor Márta Korbonits in London noticed that several of her patients with familial gigantism were from a small area in Northern Ireland. She found that they shared a specific AIP gene variant, ARG304STOP codon. The area west of Lough Neagh in Co. Tyrone and Co. Derry is now considered to be a genetic hotspot for the disease. She also connected the mutation to Charles Byrne, a famous Irish giant from the 1700s who lived in that area.
The Traveling Gene
Dungannon resident, Brendan Holland has lived most of his life in the genetic hotspot identified in Prof. Korbonits’ research. He was treated in 1972 for gigantism at St. Bartholomew’s Hospital in London, and in 2010, he met Prof. Korbonits at the hospital during the filming of the documentary Charles Byrne, the Irish Giant. He is committed to furthering Dr. Korbonits’ research and identifying others with gigantism.
Diagnosed in 1976 in Washington, D.C. at age 20 with acromegalic gigantism, Colleen Snyder searched for 45 years to find another person with the same diagnosis. During the COVID lockdown in 2020, through serendipity, a Google search, and a at-home DNA test kit, she found out that the rare AIP ARG304STOP genetic mutation caused her gigantism. The mutation was brought over to the U.S. when her great-great grandfather emigrated from Coalisland, Co. Tyrone in the genetic hotspot in Northern Ireland. She is the first person in the United States identified with the mutation.
Colleen contacted Prof. Korbonits who introduced her via Zoom to Brendan. Despite living an ocean apart, writer Colleen and historian Brendan quickly joined forces to create this book about the potentially deadly disease.
Gigantism, and the related condition, acromegaly, isn’t just about being tall. It’s caused by a tumor on the pituitary gland, which sits behind the eyes in the middle of the head. This gland controls the body’s hormones. When a tumor grows during childhood, it can produce too much growth hormone, which can lead to extreme height. But the condition comes with many other serious symptoms, like vision loss, severe headaches, joint pain, and problems with metabolism. Without treatment, many patients don’t live past age 30.
Since the discovery of the AIP gene and the variant linked to Northern Ireland, we know that some immigrant families likely carried this gene mutation with them. Only a few families in the U.S. have been identified with this Irish mutation, but it’s very likely there are more, especially in North America or Australasia. Our goal is to find these families and share information that could help prevent the serious effects of gigantism.
– Brendan Holland, Dungannon, Co. Tyrone, Northern Ireland
– Colleen Snyder, Linden, Virginia, USA
Community Testing
In 2013, Prof. Korbonits, her London team, and endocrinologists from Mexico, Romania, and Venezuela set up portable offices in Tesco parking lots in Cookstown and Dungannon to gather more than 900 DNA samples from local residents in Co. Tyrone over two weekends. The screening identified families with the same mutation and many family members with manifestations of the disease. Statistical analysis determined the founder of this particular mutation in Northern Ireland lived over 100 generations ago and could explain the many legends and folk tales about giants in Irish folklore.
Prof. Márta Korbonits, MD, PhD, Professor of Endocrinology and Metabolism, Queen Mary University of London and Barts Health NHS Trust, London, United Kingdom
Ronan McCloskey, producer and director, Charles Byrne: The Irish Giant
In 2010, Ronan McCloskey began filming the BBC documentary Charles Byrne: The Irish Giant, originally commissioned as a biography of the famed Irish giant who died in 1783. A native of Omagh in Northern Ireland, McCloskey met modern-day giant Brendan Holland during his research for the film and invited him to London to see Byrne’s skeleton during filming. When McCloskey contacted the Hunterian Museum where the giant’s skeleton had been displayed since his death, officials told him that researcher Prof. Korbonits had obtained Byrne’s DNA for comparison to contemporary Irish giants. When McCloskey arrived in London to see Byrne’s skeleton and meet Prof. Korbonits, it quickly became apparent that the documentary would be much more than a simple biography. McCloskey introduced Prof. Korbonits to Brendan who would play a pivotal role in Korbonits’ research, and he chronicled the story of Korbonits’ groundbreaking research AIP Mutation in Pituitary Adenomas in the 18th Century and Today published to acclaim in the New England Journal of Medicine in 2011.
St. Bartholomew’s Hospital, London, United Kingdom
Celebrating its 900th anniversary in 2023, St. Bartholomew’s Hospital or Barts has played a crucial role in the diagnosis of gigantism and the research detailing its cause. Established in 1123 by visionary monk Rahere, Barts has long engaged in cutting-edge research into the panorama of human diseases and conditions. In May 2022, Colleen traveled to Barts with her sister Cherie Moye, who is a carrier of the AIP gene, to meet Prof. Korbonits, her mentor renowned endocrinologist Prof. Mike Besser, and Dr. Ben Loughrey, a fellow in the genetics of pituitary adenomas. Brendan and his son Stephen made the journey as well. It was a homecoming for Brendan who was treated there, and an opportunity to learn more about the disease and related research. For example, studies continue on the effect of the AIP gene mutation on carriers. Not everyone who gets the AIP mutation from their parent goes on to develop the disease. It is unclear why the disease only occurs before the age of 25 and why only 25% of those who carry the defective gene develop the disease in childhood. At Prof. Korbonits’ laboratory in the Centre of Endocrinology at Queen Mary University of London, researchers contine to study the AIP gene and related genetic disorders.
FIPA WEBSITE
Familal isolated pituitary adenoma (FIPA) is a pituitary tumor that is caused by a genetic mutation that runs in a family. The AIP ARG304STOP gene mutation that is found in Northern Ireland is one type of FIPA. For more information about FIPA in general and more detailed information about the AIP mutation found in Northern Ireland, go to the Queen Mary University of London website https://www.qmul.ac.uk/fipa-patients/
CONTACT US
We are committed to reaching out and finding families affected by the AIP genetic mutation. We want to hear your story. You can contact Colleen Snyder at info@insearchofgiants.org or Brendan Holland at brendan@promaxequipment.com for more information.